7.91
+0.21
+(2.70%)
At close: April 15 at 9:00:34 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | 222.84M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 665.12M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 12X1.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/18/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/12/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 1/28/2025 |
Related Tickers
RXK3.MU SELLAS Life Sciences Group Inc
1.0470
+5.49%
SAVA.MX Cassava Sciences, Inc.
57.20
+0.12%
I9SA.HA Verona Pharma PLC
51.80
+0.78%
IPSC Century Therapeutics, Inc.
0.5010
+0.36%
KYTX Kyverna Therapeutics, Inc.
1.9850
-10.99%
ANVS Annovis Bio, Inc.
1.2200
-1.61%
CRDF Cardiff Oncology, Inc.
2.9400
+5.38%
CYTK Cytokinetics, Incorporated
38.56
-3.14%
SANA Sana Biotechnology, Inc.
1.7000
-6.08%
GPCR Structure Therapeutics Inc.
18.90
-0.26%